Pedro Rafael Saramago Goncalves

Pedro Rafael Saramago Goncalves, Dr

Mr

Former affiliations

Network

Martin Bland

Person: Academic

Catherine Elizabeth Hewitt

  • Health Sciences - Professor - Health Sciences, Deputy Head of Department - Research

Person: Academic

Ian Watt

Person: Academic

Monica Ines

  • Pfizer Portugal

External person

Jorge Felix

  • Exigo Consultores

External person

Melissa Harden

  • Centre for Reviews and Dissemination

External person

Manuel Espinoza

  • Pontificia Universidad Catolica de Chile, Factultad de Medicina

External person

Alex Sutton

  • Department of Health Sciences, University of Leicester,

External person

Ian Chetter

  • HYMS (HULL YORK MEDICAL SCHOOL)

External person

Karen Lamb

  • Leeds community wound prevention and management service

External person

Kath Wright

  • Centre for Reviews and Disseminations, University of York, York, UK.

External person

Nikki Stubbs

  • Leeds community wound prevention and management service

External person

Joana Ferreira

  • Instituto Superior Tecnico

External person

Alex J. Sutton

  • Univ Leicester, University of Leicester, Dept Hlth Sci
  • University of Leicester
  • University of Leicester

External person

Kalpita Joshi

  • York Trials Unit, Department of Health Sciences, University of York, York, North Yorkshire, UK.

External person

Kath Wright

  • University of York

External person

Maria do Céu Teixeira

  • INFARMED IP - Health Technology Assessment Committee

External person

Richard Morley

  • University of York

External person

Julian Perelman

  • Universidade Nova de Lisboa

External person

Ana Pinto

  • Pfizer Portugal

External person

Matthew Lees

  • University of York

External person

Joao Vaz

  • Portuguese National Association of Pharmacies

External person

Alexander Szubert

  • Medical Research Council - Clinical Trials Unit (MRC CTU)

External person

Peter Wilson

  • Cheshire and Wirral Partnership NHS Foundation Trust

External person

Zilda Mendes

  • Portuguese National Association of Pharmacies

External person

Paula Veiga

  • Universidade do Minho

External person

Kath Wright

  • Centre for Reviews and Dissemination
  • Centre for Reviews and Dissemination (CRD),University of York,[email protected].
  • University of York

External person

John Williams

  • UNIVERSITY OF OTAGO

External person

Sónia Caldeira

  • INFARMED IP - Health Technology Assessment Committee

External person

mark sculpher

  • Centre for Health Economics, University of York

External person

Lara Ferreira

  • Universidade do Algarve

External person

Ana Gordo

  • Pfizer Portugal

External person

Kamran Khan

  • University of Warwick,

External person

John Kelly

  • Division of Surgery and Interventional Science, Faculty of Medical Sciences, University College London, London, UK; Department of Urology, University College London Hospitals NHS Foundation Trust, London, UK.

External person

Elizabeth George

  • Medical Research Council Clinical Trials Unit, University College London, London. UK.

External person

Susan Mary O'Meara

  • UNIVERSITY OF MANCHESTER
  • University of York

External person

Andrew L. Clark

  • 1] Castle Hill Hospital, Castle Rd, Cottingham, East Yorkshire, UK [2] Hull York Medical School, University of Hull, Hull, UK.

External person

Jennifer Bostock

  • University of Kent
  • Public Contributor
  • London School of Hygiene and Tropical Medicine

External person

Claudia Furtado

  • INFARMED IP - Health Technology Assessment Committee

External person

Antonio Faustino

  • Pfizer Portugal

External person

George chagaluka

  • University of Malawi College of Medicine

External person

Wei Shen Tan

  • Division of Surgery and Interventional Science, Faculty of Medical Sciences, University College London, London, UK; Department of Urology, UCLH NHS Foundation Trust, London, UK.
  • Imperial Urology-Division of Surgery, Imperial College London, London, UK; Imperial Urology, Imperial College Healthcare NHS Trust, London, UK.

External person

H Lachmann

  • National Amyloidosis Centre, University College London and Royal Free London NHS Foundation Trust

External person

A Wechalekar

  • National Amyloidosis Centre, University College London and Royal Free London NHS Foundation Trust

External person

Nuria Porta

  • Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, UK.

External person

Federico Augustovski

  • Health Economic Evaluation and Technology Assessment, Institute for Clinical Effectiveness and Health Policy (IECS)
  • Institute for Clinical Effectiveness and Health Policy (IECS)
  • CONICET
  • Universidad de Buenos Aires

External person

Emma Hall

  • Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, UK.

External person

Alessandro Grosso

  • Centre for Health Economics, University of York

External person